[PHARMA] YoY TTM Result on 31-Mar-2013 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
15-May-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2013
Quarter
31-Mar-2013 [#1]
Profit Trend
QoQ- -6.34%
YoY- -11.57%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
Revenue 2,276,603 2,126,165 1,914,972 1,865,940 1,582,398 1,446,116 1,304,640 9.71%
PBT 100,648 126,033 94,232 97,283 94,349 54,823 73,685 5.32%
Tax -29,520 -26,528 -35,978 -37,985 -28,102 -18,223 -17,340 9.26%
NP 71,128 99,505 58,254 59,298 66,247 36,600 56,345 3.95%
-
NP to SH 70,629 99,421 56,646 57,797 65,358 36,561 54,977 4.25%
-
Tax Rate 29.33% 21.05% 38.18% 39.05% 29.79% 33.24% 23.53% -
Total Cost 2,205,475 2,026,660 1,856,718 1,806,642 1,516,151 1,409,516 1,248,295 9.94%
-
Net Worth 515,906 528,173 515,022 484,829 474,161 437,661 439,675 2.69%
Dividend
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
Div 69,935 80,234 42,973 41,189 44,120 50,261 97,382 -5.36%
Div Payout % 99.02% 80.70% 75.86% 71.27% 67.51% 137.47% 177.13% -
Equity
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
Net Worth 515,906 528,173 515,022 484,829 474,161 437,661 439,675 2.69%
NOSH 258,859 258,908 258,805 117,676 117,657 107,007 106,977 15.85%
Ratio Analysis
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
NP Margin 3.12% 4.68% 3.04% 3.18% 4.19% 2.53% 4.32% -
ROE 13.69% 18.82% 11.00% 11.92% 13.78% 8.35% 12.50% -
Per Share
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
RPS 879.48 821.20 739.93 1,585.65 1,344.91 1,351.41 1,219.55 -5.29%
EPS 27.28 38.40 21.89 49.11 55.55 34.17 51.39 -10.00%
DPS 27.00 31.00 16.61 35.00 37.50 47.00 91.00 -18.31%
NAPS 1.993 2.04 1.99 4.12 4.03 4.09 4.11 -11.35%
Adjusted Per Share Value based on latest NOSH - 117,676
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
RPS 157.96 147.52 132.87 129.47 109.80 100.34 90.52 9.71%
EPS 4.90 6.90 3.93 4.01 4.53 2.54 3.81 4.27%
DPS 4.85 5.57 2.98 2.86 3.06 3.49 6.76 -5.37%
NAPS 0.358 0.3665 0.3573 0.3364 0.329 0.3037 0.3051 2.69%
Price Multiplier on Financial Quarter End Date
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
Date 31/03/16 31/03/15 31/03/14 29/03/13 30/03/12 31/03/11 31/03/10 -
Price 5.76 6.00 4.46 8.26 5.90 5.73 4.27 -
P/RPS 0.65 0.73 0.60 0.52 0.44 0.42 0.35 10.85%
P/EPS 21.11 15.62 20.38 16.82 10.62 16.77 8.31 16.79%
EY 4.74 6.40 4.91 5.95 9.42 5.96 12.04 -14.37%
DY 4.69 5.17 3.72 4.24 6.36 8.20 21.31 -22.28%
P/NAPS 2.89 2.94 2.24 2.00 1.46 1.40 1.04 18.55%
Price Multiplier on Announcement Date
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
Date 13/05/16 18/05/15 14/05/14 15/05/13 03/05/12 13/05/11 26/05/10 -
Price 5.60 6.91 4.70 9.26 5.90 5.05 4.71 -
P/RPS 0.64 0.84 0.64 0.58 0.44 0.37 0.39 8.59%
P/EPS 20.52 17.99 21.47 18.85 10.62 14.78 9.16 14.37%
EY 4.87 5.56 4.66 5.30 9.42 6.77 10.91 -12.56%
DY 4.82 4.49 3.53 3.78 6.36 9.31 19.32 -20.64%
P/NAPS 2.81 3.39 2.36 2.25 1.46 1.23 1.15 16.04%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment